June 17, 2024 17:49 (IST)
Follow us:
Aurobindo Pharma receives USFDA approval for drug related to moderate dementia
Hyderabad/Mumbai, Mar 29 (IBNS) Aurobindo Pharma Limited, which manufactures generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that the company has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivastigmine Tartrate Capsules USP, 1.5 mg, 3 mg, 4.5 mg and 6 mg.
This product is expected to be launched in the first quarter of fiscal year 2016-17.
The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Exelon Capsules, 1.5 mg, 3 mg, 4.5 mg and 6 mg, of Novartis Pharmaceuticals Corporation, said the company.
Naproxen Sodium Tablets is used in the treatment of mild moderate dementia of the Alzheimer's and Parkinson's disease.
The approved product has an estimated market size of US$ 26.7 million for the twelve months ending January 2016 according to IMS.
This is the 67th ANDA (including 14 tentative approvals) to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing oral non-antibiotic products.
Aurobindo now has a total of 246 ANDA approvals (211 Final approvals including 10 from Aurolife Pharma LLC and 35 tentative approvals) from USFDA.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
CII President Sanjiv Puri feels India will be third-largest economy in next few years Mon, Jun 17 2024
SoftBank develops AI-driven voice tech to deal with angry customers Fri, Jun 14 2024
PNB MetLife announces Rs 930 cr benefitting 5.82 lakh customers Fri, Jun 14 2024
Adani Enterprises promoters raise stake to 73.95% in the company Fri, Jun 14 2024
Hyundai to liquidate 17.5% stake in Hyundai Motor India to raise up to $3 billion via IPO Fri, Jun 14 2024
Vodafone Group to sell entire $2.3 bn stake in Indus Towers Fri, Jun 14 2024
Bisk Farm introduces two new products in its 'Eat Fit' range Thu, Jun 13 2024